 |
 Video: What is a Stock Split?
|
|
|
| Codexis discovers, develops and sells enzymes and other proteins to its clients. Co.'s business segments are: Performance Enzymes, which uses its technology to develop enzymes for customers using next generation sequencing and polymerase chain reaction for in vitro molecular diagnostic and molecular biology research applications, as well DNA/RNA synthesis and health monitoring applications; and Novel Biotherapeutics, which discovers, improves, and/or develops biotherapeutic drug candidates, including CDX-6114 for the potential treatment of hyperphenylalaninemia. Co.'s products include biocatalysts, chemical intermediates and Codex® biocatalyst panels and kits. According to our Codexis stock split history records, Codexis has had 0 splits. | |
|
Codexis (CDXS) has 0 splits in our Codexis stock split history database.
Looking at the Codexis stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Codexis shares, starting with a $10,000 purchase of CDXS, presented on a split-history-adjusted basis factoring in the complete Codexis stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/30/2014 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$1.70 |
|
| End price/share: |
$2.66 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
56.47% |
|
| Average Annual Total Return: |
4.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$15,647.07 |
|
| Years: |
10.00 |
|
|
|
|
|
